Literature DB >> 29166603

Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.

Sarah E Lutz1, Julian R Smith2, Dae Hwan Kim3, Carl V L Olson3, Kyle Ellefsen3, Jennifer M Bates4, Sunil P Gandhi3, Dritan Agalliu5.   

Abstract

Lymphocytes cross vascular boundaries via either disrupted tight junctions (TJs) or caveolae to induce tissue inflammation. In the CNS, Th17 lymphocytes cross the blood-brain barrier (BBB) before Th1 cells; yet this differential crossing is poorly understood. We have used intravital two-photon imaging of the spinal cord in wild-type and caveolae-deficient mice with fluorescently labeled endothelial tight junctions to determine how tight junction remodeling and caveolae regulate CNS entry of lymphocytes during the experimental autoimmune encephalomyelitis (EAE) model for multiple sclerosis. We find that dynamic tight junction remodeling occurs early in EAE but does not depend upon caveolar transport. Moreover, Th1, but not Th17, lymphocytes are significantly reduced in the inflamed CNS of mice lacking caveolae. Therefore, tight junction remodeling facilitates Th17 migration across the BBB, whereas caveolae promote Th1 entry into the CNS. Moreover, therapies that target both tight junction degradation and caveolar transcytosis may limit lymphocyte infiltration during inflammation.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caveolin1; Claudin5; blood-brain barrier; caveolae; endothelium; experimental autoimmune encephalomyelitis; intravital microscopy; multiple sclerosis; tight junction; transcytosis

Mesh:

Substances:

Year:  2017        PMID: 29166603      PMCID: PMC5728697          DOI: 10.1016/j.celrep.2017.10.094

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  70 in total

1.  Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway.

Authors:  C Tiruppathi; W Song; M Bergenfeldt; P Sass; A B Malik
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

2.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

Review 3.  Cavin family proteins and the assembly of caveolae.

Authors:  Oleksiy Kovtun; Vikas A Tillu; Nicholas Ariotti; Robert G Parton; Brett M Collins
Journal:  J Cell Sci       Date:  2015-04-01       Impact factor: 5.285

4.  Loss of astrocyte connexins 43 and 30 does not significantly alter susceptibility or severity of acute experimental autoimmune encephalomyelitis in mice.

Authors:  Sarah E Lutz; Cedric S Raine; Celia F Brosnan
Journal:  J Neuroimmunol       Date:  2012-02-18       Impact factor: 3.478

Review 5.  Understanding the functions and relationships of the glymphatic system and meningeal lymphatics.

Authors:  Antoine Louveau; Benjamin A Plog; Salli Antila; Kari Alitalo; Maiken Nedergaard; Jonathan Kipnis
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

6.  Cutting edge: loss of α4 integrin expression differentially affects the homing of Th1 and Th17 cells.

Authors:  Simon Glatigny; Rebekka Duhen; Mohamed Oukka; Estelle Bettelli
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

7.  The gut microbiota influences blood-brain barrier permeability in mice.

Authors:  Viorica Braniste; Maha Al-Asmakh; Czeslawa Kowal; Farhana Anuar; Afrouz Abbaspour; Miklós Tóth; Agata Korecka; Nadja Bakocevic; Lai Guan Ng; Ng Lai Guan; Parag Kundu; Balázs Gulyás; Christer Halldin; Kjell Hultenby; Harriet Nilsson; Hans Hebert; Bruce T Volpe; Betty Diamond; Sven Pettersson
Journal:  Sci Transl Med       Date:  2014-11-19       Impact factor: 17.956

8.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation.

Authors:  Hania Kebir; Katharina Kreymborg; Igal Ifergan; Aurore Dodelet-Devillers; Romain Cayrol; Monique Bernard; Fabrizio Giuliani; Nathalie Arbour; Burkhard Becher; Alexandre Prat
Journal:  Nat Med       Date:  2007-09-09       Impact factor: 53.440

Review 9.  Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.

Authors:  Melissa A Lopes Pinheiro; Gijs Kooij; Mark R Mizee; Alwin Kamermans; Gaby Enzmann; Ruth Lyck; Markus Schwaninger; Britta Engelhardt; Helga E de Vries
Journal:  Biochim Biophys Acta       Date:  2015-10-23

10.  Practical guide to the induction of relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.

Authors:  Sarah Al-Izki; Gareth Pryce; Janet K O'Neill; Colin Butter; Gavin Giovannoni; Sandra Amor; David Baker
Journal:  Mult Scler Relat Disord       Date:  2011-09-15       Impact factor: 4.339

View more
  46 in total

1.  AKT2 maintains brain endothelial claudin-5 expression and selective activation of IR/AKT2/FOXO1-signaling reverses barrier dysfunction.

Authors:  Richard S Beard; Brian A Hoettels; Jamie E Meegan; Travis S Wertz; Byeong J Cha; Xiaoyuan Yang; Julia T Oxford; Mack H Wu; Sarah Y Yuan
Journal:  J Cereb Blood Flow Metab       Date:  2018-12-21       Impact factor: 6.200

2.  Th17 lymphocytes drive vascular and neuronal deficits in a mouse model of postinfectious autoimmune encephalitis.

Authors:  Maryann P Platt; Kevin A Bolding; Charlotte R Wayne; Sarah Chaudhry; Tyler Cutforth; Kevin M Franks; Dritan Agalliu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

3.  Blood-brain barrier resealing in neuromyelitis optica occurs independently of astrocyte regeneration.

Authors:  Anne Winkler; Claudia Wrzos; Michael Haberl; Marie-Theres Weil; Ming Gao; Wiebke Möbius; Francesca Odoardi; Dietmar R Thal; Mayland Chang; Ghislain Opdenakker; Jeffrey L Bennett; Stefan Nessler; Christine Stadelmann
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 4.  Imaging the dynamic interactions between immune cells and the neurovascular interface in the spinal cord.

Authors:  Nozha Borjini; Evi Paouri; Reshmi Tognatta; Katerina Akassoglou; Dimitrios Davalos
Journal:  Exp Neurol       Date:  2019-08-28       Impact factor: 5.330

5.  Targeting Biological Barriers: Turning a Wall into a Therapeutic Springboard.

Authors:  S Moein Moghimi; Kenneth A Howard
Journal:  Mol Ther       Date:  2018-03-21       Impact factor: 11.454

Review 6.  Neuronal and glial regulation of CNS angiogenesis and barriergenesis.

Authors:  Saptarshi Biswas; Azzurra Cottarelli; Dritan Agalliu
Journal:  Development       Date:  2020-05-01       Impact factor: 6.868

Review 7.  Investigating the blood-spinal cord barrier in preclinical models: a systematic review of in vivo imaging techniques.

Authors:  Joshua Bakhsheshian; Ben A Strickland; William J Mack; Berislav V Zlokovic
Journal:  Spinal Cord       Date:  2021-03-19       Impact factor: 2.772

8.  Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.

Authors:  Maryna Samus; Yu-Tung Li; Lydia Sorokin; Klemens Rottner; Dietmar Vestweber
Journal:  J Neurosci       Date:  2020-01-07       Impact factor: 6.167

9.  Basic physiology of the blood-brain barrier in health and disease: a brief overview.

Authors:  Mehmet Kaya; Bulent Ahishali
Journal:  Tissue Barriers       Date:  2020-11-15

10.  A Unique Collateral Artery Development Program Promotes Neonatal Heart Regeneration.

Authors:  Soumyashree Das; Andrew B Goldstone; Hanjay Wang; Justin Farry; Gaetano D'Amato; Michael J Paulsen; Anahita Eskandari; Camille E Hironaka; Ragini Phansalkar; Bikram Sharma; Siyeon Rhee; Elya Ali Shamskhou; Dritan Agalliu; Vinicio de Jesus Perez; Y Joseph Woo; Kristy Red-Horse
Journal:  Cell       Date:  2019-01-24       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.